Inovor Technologies is blending sovereign design with global partnerships to redefine Australia’s satellite manufacturing ...

A Breakthrough Study on Ferroptosis Reinforces Continual-G's Emphasis on Internal Cellular Activity as a Central Stage for Long-Term Health ...

At CES 2026, Govee is unveiling a new generation of core lighting technologies, alongside a preview of three flagship products that push ...

Background Prehospital delays remain critical barriers to timely acute coronary syndrome (ACS) care, particularly for ...

Seeking Alpha is proud to welcome Vega North as a new contributing analyst. You can become one too! Share your best ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

So, in a nutshell, there’s a lot to take into account when picking a winner in each of the Australian Camera Magazine Imaging ...

Aribio (CEO Jeong Jae-joon) announced on the 30th that its own dementia electronic drug 'GVD-01' was finally selected as the ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Researchers have added to a stack of existing evidence that 40 Hz gamma frequencies could help to treat Alzheimer's disease.

Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for ...

Sobi (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant (emapalumab) for interferon-gamma (IFN?)-driven ...